NEWSBRIEF

UPDATE

NEWSBRIEF

NEWSBRIEF

NEWSBRIEF

NEWSBRIEF

Mark Boguski cut his teeth at NCBI at the height of the genome sequencing era before moving on to lead R&D at Rosetta Inpharmatics just as the field of microarray analysis was taking off; in other words, his career has mirrored major shifts in the field of bioinformatics itself.

Gene Logic last week reduced its pro forma revenue predictions for the 2003 fiscal year by 10 percent...Subscribers: click headline for more

Rescentris has released the Genomic Workspace, a package to visualize, annotate, and edit sequence information in BSML format, along with the Genomic Viewer, a free, read-only version of the workspace.

Direct Wireless Completes Barnhill Group Acquisition Direct Wireless Communications last week wrapped up its acquisition of genomics and bioinformatics consulting firm the Barnhill Group of Savannah, Ga.

GW REPORTS

NEWSBRIEF

When it comes to hot topics in microarray analysis, the latest clustering algorithms and statistical calisthenics don t necessarily top the list for many pharmaceutical companies...Subscribers: click headline for more

Prototype disease marker genome annotation system. Amount: $99,783. Start date: Aug. 2003. Expires: Nov. 2003. Principal investigator: Martin Reese. Institution: Omicia. NIH Institute: NHGRI.

David Kulp, formerly vice president of bioinformatics at Affymetrix, has accepted a faculty position in the computer science department at University of Massachusetts, Amherst, where he’ll be starting a research program in bioinformatics.

NEWSBRIEF

NEWSBRIEF

A pair of concurrent Cambridge Healthtech Institute meetings held in Baltimore, Md., last week highlighted the fuzzy line that divides data integration and data analysis at biopharmaceutical companies today...Subscribers: click headline for more

Bill Rich -- the man who built a company around SELDI mass spec technology -- does not care about mass specs...Subscribers: click headline for more

Benitec said last week that it has named John Rossi as chairman of its scientific advisory board....Subscribers: click headline for more

NEWSBRIEF

At the UBS Global Life Sciences Conference held in New York this week, major proteomics instrument vendors emphasized platform integration, mark-eting their products to non-techie biologists, and carving out new niches in the proteomics market as key strategies in the coming quarters......Subscribers: click headline for more

Richard DiMarchi has been appointed CEO and Thomas Daniel has become chief scientific officer of San Diego-based Ambrx.

Archemix and Somalogic to Collaborate on Aptamers Cambridge, Mass.-based Archemix and Boulder, Colo.-based SomaLogic announced this week that they will collaborate on the development and marketing of aptamers for diagnostics and therapeutics applications.